Why the study?
Data on the efficacy and safety of therapeutic enoxaparin in obese patients needed systematic summarization to identify gaps and guide future research.
What are the efficacy and safety outcomes of therapeutic enoxaparin dosing regimens in obese adult patients?
Comparison
Therapeutic enoxaparin dosing regimens
Design
Systematic review
Authors
Loading...
Enoxaparin dosing in obesity shows variable outcomes and lacks standardization; leaves open optimal regimens for prospective trials.
What are the efficacy and safety outcomes of therapeutic enoxaparin dosing regimens in obese adult patients?
There is currently inadequate evidence to support a single optimal therapeutic enoxaparin dosing strategy in obese patients, though anti-Xa monitoring may be appropriate to guide dosing.
Appay et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: